US5702359A
(en)
*
|
1995-06-06 |
1997-12-30 |
Genetronics, Inc. |
Needle electrodes for mediated delivery of drugs and genes
|
US5993434A
(en)
*
|
1993-04-01 |
1999-11-30 |
Genetronics, Inc. |
Method of treatment using electroporation mediated delivery of drugs and genes
|
US6261281B1
(en)
*
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
BR9810369A
(pt)
|
1997-06-30 |
2000-09-05 |
Rhone Poulenc Rorer Sa |
Processo de transferência de ácido nucleico para o interior de um ou mais músculos estriados, in vivo, composição, ácido mucleico e campo elétrico, e, produto de combinação
|
US6528315B2
(en)
*
|
1997-06-30 |
2003-03-04 |
Aventis Pharma S.A. |
Method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor
|
US6241701B1
(en)
|
1997-08-01 |
2001-06-05 |
Genetronics, Inc. |
Apparatus for electroporation mediated delivery of drugs and genes
|
US6055453A
(en)
|
1997-08-01 |
2000-04-25 |
Genetronics, Inc. |
Apparatus for addressing needle array electrodes for electroporation therapy
|
US20040229363A1
(en)
*
|
1998-06-24 |
2004-11-18 |
Ed Nolan |
High efficiency transfection based on low electric field strength, long pulse length
|
US7922709B2
(en)
|
1998-07-13 |
2011-04-12 |
Genetronics, Inc. |
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
US6678556B1
(en)
|
1998-07-13 |
2004-01-13 |
Genetronics, Inc. |
Electrical field therapy with reduced histopathological change in muscle
|
US6697669B2
(en)
|
1998-07-13 |
2004-02-24 |
Genetronics, Inc. |
Skin and muscle-targeted gene therapy by pulsed electrical field
|
CA2361601A1
(en)
*
|
1999-02-08 |
2000-08-10 |
Cheryl Goldbeck |
Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
|
US6593130B1
(en)
|
1999-04-16 |
2003-07-15 |
The Regents Of The University Of California |
Method and apparatus for ex vivo and in vivo cellular electroporation of gene protein or drug therapy
|
AU2001241958A1
(en)
*
|
2000-03-03 |
2001-09-17 |
Valentis, Inc. |
Improved poloxamer and poloxamine compositions for nucleic acid delivery
|
US6928318B2
(en)
|
2000-05-22 |
2005-08-09 |
Merck & Co., Inc. |
System and method for assessing the performance of a pharmaceutical agent delivery system
|
US6733485B1
(en)
|
2001-05-25 |
2004-05-11 |
Advanced Bionics Corporation |
Microstimulator-based electrochemotherapy methods and systems
|
US20040204669A1
(en)
*
|
2001-07-05 |
2004-10-14 |
Hofmann Gunter A. |
Apparatus for electroporation mediated delivery for drugs and genes
|
US7713740B2
(en)
*
|
2001-08-24 |
2010-05-11 |
University Of South Florida |
Method of using electric fields to facilitate the entry of molecules into cells in vivo
|
DK1436397T3
(da)
|
2001-10-11 |
2010-08-09 |
Merck Sharp & Dohme |
Hepatitis C virus vaccine
|
ES2344253T3
(es)
|
2001-10-11 |
2010-08-23 |
MERCK SHARP & DOHME CORP. |
Vacuna contra el virus de la hepatitis c.
|
IL161862A0
(en)
*
|
2001-11-08 |
2005-11-20 |
Univ California |
Methods and compositions for correction of cardiac conduction disturbances
|
JP2005513062A
(ja)
*
|
2001-12-14 |
2005-05-12 |
ジェネトロニクス インコーポレイテッド |
パルス電場を使用した粒子支援ポリヌクレオチド免疫方法
|
JP2005527490A
(ja)
*
|
2002-01-18 |
2005-09-15 |
イノヴィオ アーエス |
筋肉内投与のための二重特異性抗体dna構築物
|
US8209006B2
(en)
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
US7245963B2
(en)
*
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
JP2005518904A
(ja)
|
2002-03-07 |
2005-06-30 |
マーク アンド カンパニー インコーポレイテッド |
電気的刺激の側面を備えた臨床用注射器
|
US6912417B1
(en)
*
|
2002-04-05 |
2005-06-28 |
Ichor Medical Systmes, Inc. |
Method and apparatus for delivery of therapeutic agents
|
ATE402732T1
(de)
|
2002-04-16 |
2008-08-15 |
Cyto Pulse Sciences Inc |
Verfahren zur behandlung von biologischen materialien mit übersetzenden elektrischen feldern und elektroden-polaritäts-umkehr
|
US20040106896A1
(en)
*
|
2002-11-29 |
2004-06-03 |
The Regents Of The University Of California |
System and method for forming a non-ablative cardiac conduction block
|
US7328064B2
(en)
|
2002-07-04 |
2008-02-05 |
Inovio As |
Electroporation device and injection apparatus
|
NZ585119A
(en)
|
2004-03-08 |
2011-08-26 |
Ichor Medical Systems Inc |
Medical injector with surrounding electrical field generating penetrating electrodes
|
TW200613554A
(en)
|
2004-06-17 |
2006-05-01 |
Wyeth Corp |
Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
|
AU2006226753A1
(en)
*
|
2005-03-19 |
2006-09-28 |
The Regents Of The University Of California |
Ultra low strength electric field network-mediated ex vivo gene, protein and drug delivery in cells
|
EP2570423B1
(en)
|
2005-06-17 |
2023-05-03 |
MSD Italia S.r.l. |
Hepatitis C virus nucleic acid vaccine
|
US20070190032A1
(en)
*
|
2006-02-13 |
2007-08-16 |
Oncolytics Biotech Inc. |
Use of Local Immune Suppression to Enhance Oncolytic Viral Therapy
|
AU2007322075B2
(en)
|
2006-11-17 |
2013-07-25 |
Genetronics, Inc. |
Methods of enhancing immune response using electroporation-assisted vaccination and boosting
|
DK2222697T3
(da)
|
2007-11-01 |
2013-03-11 |
Perseid Therapeutics Llc |
Immunsuppressive polypeptider og nukleinsyrer
|
CA2720166A1
(en)
*
|
2008-04-04 |
2009-10-08 |
David B. Weiner |
Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
|
KR101652767B1
(ko)
|
2008-04-04 |
2016-08-31 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Il-28을 이용한 백신 및 면역치료제, 및 그를 사용하는 방법 및 조성물
|
EP2147697A1
(en)
|
2008-07-21 |
2010-01-27 |
Centre National De La Recherche Scientifique-CNRS |
Process and device for applying electric fields into conductive material
|
EP2156860A1
(en)
|
2008-08-20 |
2010-02-24 |
Centre National De La Recherche Scientifique-CNRS |
Method for producing insulated electrodes for applying electric fields into conductive material
|
US20100298697A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Medtronic, Inc. |
Method and devices for improved efficiency of rna delivery to cells
|
US8207138B2
(en)
|
2009-05-19 |
2012-06-26 |
Medtronic, Inc. |
Methods and devices for improved efficiency of RNA delivery to cells
|
CN102821790A
(zh)
|
2009-09-14 |
2012-12-12 |
宾夕法尼亚大学托管会 |
包含IL-15受体α和/或编码IL-15受体α的核酸分子的疫苗和免疫治疗剂,以及其使用方法
|
IN2012DN03928A
(ko)
|
2009-11-02 |
2015-09-04 |
Univ Pennsylvania |
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
CN102781952B
(zh)
|
2010-02-08 |
2015-09-02 |
宾夕法尼亚大学托管会 |
编码rantes的核酸分子、包含其的组合物以及其使用方法
|
WO2012047679A2
(en)
|
2010-09-27 |
2012-04-12 |
The Trustees Of The University Of Pennsylvania |
Consensus antigen constructs and vaccines made there form, and methods of using same to treat malaria
|
MX346784B
(es)
|
2010-11-12 |
2017-03-31 |
Inovio Pharmaceuticals Inc |
Antigenos prostaticos de consenso, molecula de acido nucleico que los codifica y vacuna y usos que los comprenden.
|
EA033467B1
(ru)
|
2011-01-31 |
2019-10-31 |
Univ Pennsylvania |
Молекула нуклеиновой кислоты для индукции иммунного ответа против герпесвируса и ее применение
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
EP3760227A1
(en)
|
2011-02-11 |
2021-01-06 |
The Trustees of the University of Pennsylvania |
Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same
|
US9457183B2
(en)
|
2011-06-15 |
2016-10-04 |
Tripep Ab |
Injection needle and device
|
ES2758713T3
(es)
|
2011-07-11 |
2020-05-06 |
Inovio Pharmaceuticals Inc |
Vacuna de ADN contra el virus de Lassa
|
CA2858884A1
(en)
|
2011-12-12 |
2013-06-20 |
The Trustees Of The University Of Pennsylvania |
Proteins comprising mrsa pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat mrsa infections
|
KR102101819B1
(ko)
|
2011-12-12 |
2020-04-21 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
개선된 il-12 유전적 컨스트럭트 및 백신을 포함하는 조성물, 면역치료제 및 이를 이용하는 방법
|
JP2015514132A
(ja)
|
2012-04-10 |
2015-05-18 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
ヒト呼吸器合胞体ウイルスコンセンサス抗原、核酸構築物、およびそれらから作製されるワクチン、ならびにその使用方法
|
KR20220012403A
(ko)
|
2012-04-12 |
2022-02-03 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
필로바이러스 공통 항원, 이로부터 제조된 핵산 구조체 및 백신, 및 이를 사용하는 방법
|
DE102012013534B3
(de)
|
2012-07-05 |
2013-09-19 |
Tobias Sokolowski |
Vorrichtung für repetitive Nervenstimulation zum Abbau von Fettgewebe mittels induktiver Magnetfelder
|
WO2014064534A2
(en)
|
2012-10-05 |
2014-05-01 |
Chrontech Pharma Ab |
Injection needle, device, immunogenic compositions and method of use
|
KR102258021B1
(ko)
|
2012-12-13 |
2021-06-01 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
Wt1 백신
|
WO2015089492A2
(en)
|
2013-12-13 |
2015-06-18 |
The Trustees Of The University Of Pennsylvania |
Dna antibody constructs and method of using same
|
JP6817062B2
(ja)
|
2013-03-15 |
2021-01-20 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
蹄疫ウイルス(fmdv)コンセンサスタンパク質、そのコード配列、およびそれから作成されるワクチン
|
EP3607974A1
(en)
|
2013-03-15 |
2020-02-12 |
The Trustees of The University of Pennsylvania |
Cancer vaccines and methods of treatment using the same
|
EP3028048B1
(en)
|
2013-07-31 |
2018-09-26 |
BioVentures, LLC |
Compositions for treating and preventing cancer targeting tumor associated carbohydrate antigens
|
CN114010802A
(zh)
|
2014-12-01 |
2022-02-08 |
宾夕法尼亚大学理事会 |
Dna抗体构建体及其使用方法
|
US11491342B2
(en)
|
2015-07-01 |
2022-11-08 |
Btl Medical Solutions A.S. |
Magnetic stimulation methods and devices for therapeutic treatments
|
US10695575B1
(en)
|
2016-05-10 |
2020-06-30 |
Btl Medical Technologies S.R.O. |
Aesthetic method of biological structure treatment by magnetic field
|
US20180001107A1
(en)
|
2016-07-01 |
2018-01-04 |
Btl Holdings Limited |
Aesthetic method of biological structure treatment by magnetic field
|
US11266850B2
(en)
|
2015-07-01 |
2022-03-08 |
Btl Healthcare Technologies A.S. |
High power time varying magnetic field therapy
|
WO2017055522A1
(en)
|
2015-09-29 |
2017-04-06 |
Academisch Medisch Centrum |
Stabilized env proteins of hiv
|
US11253717B2
(en)
|
2015-10-29 |
2022-02-22 |
Btl Healthcare Technologies A.S. |
Aesthetic method of biological structure treatment by magnetic field
|
CN118184761A
(zh)
|
2016-02-05 |
2024-06-14 |
因诺维奥制药公司 |
癌症疫苗和使用其的治疗方法
|
EA038691B1
(ru)
|
2016-03-28 |
2021-10-05 |
Айкор Медикэл Системс, Инк. |
Устройство для доставки терапевтических средств
|
MX2018012376A
(es)
|
2016-04-13 |
2019-08-01 |
Synthetic Genomics Inc |
Sistemas de replicón de arterivirus recombinantes y usos de estos.
|
US11464993B2
(en)
|
2016-05-03 |
2022-10-11 |
Btl Healthcare Technologies A.S. |
Device including RF source of energy and vacuum system
|
US11247039B2
(en)
|
2016-05-03 |
2022-02-15 |
Btl Healthcare Technologies A.S. |
Device including RF source of energy and vacuum system
|
US11534619B2
(en)
|
2016-05-10 |
2022-12-27 |
Btl Medical Solutions A.S. |
Aesthetic method of biological structure treatment by magnetic field
|
US10583287B2
(en)
|
2016-05-23 |
2020-03-10 |
Btl Medical Technologies S.R.O. |
Systems and methods for tissue treatment
|
US10556122B1
(en)
|
2016-07-01 |
2020-02-11 |
Btl Medical Technologies S.R.O. |
Aesthetic method of biological structure treatment by magnetic field
|
KR20190082226A
(ko)
|
2016-10-17 |
2019-07-09 |
신테틱 제노믹스, 인코포레이티드. |
재조합 바이러스 레플리콘 시스템 및 그의 용도
|
AU2017372731B2
(en)
|
2016-12-05 |
2024-05-23 |
Janssen Pharmaceuticals, Inc. |
Compositions and methods for enhancing gene expression
|
US11344618B2
(en)
|
2017-08-26 |
2022-05-31 |
Academisch Medisch Centrum |
HIV envelope glycoprotein immunogens
|
BR112020010499A2
(pt)
|
2017-12-13 |
2020-11-24 |
Inovio Pharmaceuticals, Inc. |
vacinas de câncer de alvo de mesotelina e usos das mesmas
|
DK3737397T3
(da)
|
2017-12-13 |
2023-02-20 |
Inovio Pharmaceuticals Inc |
Cancervacciner mod PRAME og anvendelse deraf
|
KR20230116957A
(ko)
|
2017-12-13 |
2023-08-04 |
이노비오 파마수티컬즈, 인크. |
Muc16을 표적화하는 암 백신 및 이의 용도
|
US11021692B2
(en)
|
2017-12-19 |
2021-06-01 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis B virus (HBV) vaccines and uses thereof
|
US11020476B2
(en)
|
2017-12-19 |
2021-06-01 |
Janssen Sciences Ireland Unlimited Company |
Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)
|
MX2020006480A
(es)
|
2017-12-19 |
2020-09-22 |
Janssen Sciences Ireland Unlimited Co |
Vacunas contra el virus de la hepatitis b (hbv) y usos de las mismas.
|
AU2018389786A1
(en)
|
2017-12-19 |
2020-06-18 |
Bavarian Nordic A/S |
Methods and compositions for inducing an immune response against hepatitis B virus (HBV)
|
EA202091517A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и устройство для доставки вакцин против вируса гепатита b (hbv)
|
AU2019210189A1
(en)
|
2018-01-19 |
2020-08-06 |
Janssen Pharmaceuticals, Inc. |
Induce and enhance immune responses using recombinant replicon systems
|
DE202020005828U1
(de)
|
2019-04-11 |
2022-09-06 |
BTL Medical Solutions as. |
Vorrichtungen zur Schönheitsbehandlung biologischer Strukturen durch Hochfrequenz- und Magnetenergie
|
MA56520A
(fr)
|
2019-06-18 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Co |
Construction de l'interleukine 12 recombinante et ses utilisations
|
WO2020255016A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
CA3141238A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis b virus (hbv) vaccines and uses thereof
|
WO2020255038A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
WO2020255039A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and quinazoline derivatives
|
JP2022536945A
(ja)
|
2019-06-18 |
2022-08-22 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
B型肝炎ウイルス(HBV)ワクチンおよびHBVを標的化するRNAiの組合せ
|
WO2020255015A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
CA3140588A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and small molecule pdl1 or pd1 inhibitor
|
WO2020255019A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and a quinazoline derivative
|
WO2020255022A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and aminopyridine derivatives as hpk1 inhibitors
|
EP3986456A1
(en)
|
2019-06-18 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and hbv-targeting rnai
|
MA56533A
(fr)
|
2019-06-18 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Co |
Combinaison de vaccins contre le virus de l'hépatite b (vhb) et d'anticorps anti-pd-1
|
WO2020254876A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Virus-like particle delivery of hepatitis b virus (hbv) vaccines
|
US20220233684A1
(en)
|
2019-06-18 |
2022-07-28 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pd-l1 inhibitors
|
WO2020255013A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being amide derivatives
|
TWI772823B
(zh)
|
2019-06-18 |
2022-08-01 |
愛爾蘭商健生科學愛爾蘭無限公司 |
B型肝炎病毒(hbv)疫苗與蛋白殼組裝調節劑之組合
|
WO2020255035A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyrimidine derivatives
|
WO2020255010A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of recombinant interleukin 12 construct and hepatitis b virus (hbv) vaccines
|
WO2020255042A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and a pyrimidine derivative
|
EP3986454A1
(en)
|
2019-06-18 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and anti-pd-1 or anti-pd-l1 antibody
|
WO2020255017A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
EP3986563A1
(en)
|
2019-06-20 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Lipid nanoparticle or liposome delivery of hepatitis b virus (hbv) vaccines
|
EP3986457A1
(en)
|
2019-06-20 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines
|
WO2021224678A1
(en)
|
2020-05-04 |
2021-11-11 |
Btl Medical Technologies S.R.O. |
Device and method for unattended treatment of a patient
|
US11878167B2
(en)
|
2020-05-04 |
2024-01-23 |
Btl Healthcare Technologies A.S. |
Device and method for unattended treatment of a patient
|
CN116133668A
(zh)
|
2020-06-12 |
2023-05-16 |
罗切斯特大学 |
ACE-tRNA的编码和表达
|
CN116367854A
(zh)
|
2020-07-08 |
2023-06-30 |
杨森科学爱尔兰无限公司 |
针对hbv的rna复制子疫苗
|
WO2022133230A1
(en)
|
2020-12-18 |
2022-06-23 |
Janssen Pharmaceuticals, Inc. |
Combination therapy for treating hepatitis b virus infection
|
JP2024501022A
(ja)
|
2020-12-28 |
2024-01-10 |
アークトゥルス セラピューティクス, インコーポレイテッド |
Hbvを標的とする転写活性化因子様エフェクターヌクレアーゼ(talen)
|
US11896816B2
(en)
|
2021-11-03 |
2024-02-13 |
Btl Healthcare Technologies A.S. |
Device and method for unattended treatment of a patient
|
WO2023150753A1
(en)
|
2022-02-07 |
2023-08-10 |
University Of Rochester |
Optimized sequences for enhanced trna expression or/and nonsense mutation suppression
|
WO2023233290A1
(en)
|
2022-05-31 |
2023-12-07 |
Janssen Sciences Ireland Unlimited Company |
Rnai agents targeting pd-l1
|